Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 16, 2026

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
06:15

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

1.8K

Reticular Subepithelial Corneal Deposits in a Patient Receiving Niraparib Therapy.

Sahib Y Tuteja1, David Lockington

  • 1Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow, United Kingdom .

Cornea
|October 3, 2025
PubMed
Summary

Oral niraparib, a medication for ovarian cancer, may cause corneal subepithelial drug deposits. This case report details a distinct pattern of these unique corneal deposits.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment and management of dry eye disease in the UK: standardising reality-based best practice.

Eye (London, England)·2026
Same author

Corneal Stromal Thinning and Posterior Irregularity After DMEK: Clinical Observations and Biophysical Hypotheses.

Cornea·2026
Same author

Survey of UKISCRS members regarding dropless cataract surgery - current practice and future potential.

Eye (London, England)·2025
Same author

Clinical Dilemmas in Coexisting Ocular Surface Disease and Glaucoma.

Seminars in ophthalmology·2025
Same author

Timing of posterior capsular rupture during cataract surgery.

Eye (London, England)·2025
Same author

Artificial intelligence versus ophthalmology experts: Comparative analysis of responses to blepharitis patient queries.

European journal of ophthalmology·2025

Area of Science:

  • Ophthalmology
  • Oncology
  • Pharmacology

Background:

  • Ovarian cancer treatment often involves maintenance therapy.
  • Niraparib is a newly approved oral medication for ovarian cancer maintenance therapy.
  • Ocular side effects of systemic medications require careful monitoring.
Keywords:
PARP inhibitorcorneal drug depositscorneal opacityniraparib

More Related Videos

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures
04:48

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures

Published on: November 22, 2024

770

Related Experiment Videos

Last Updated: Jan 16, 2026

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
06:15

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

1.8K
Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures
04:48

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures

Published on: November 22, 2024

770